• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于皮下微透析和群体药代动力学模型的证据,为病态肥胖女性接受减重手术时头孢唑林的有效预防剂量。

Efficacious Cefazolin Prophylactic Dose for Morbidly Obese Women Undergoing Bariatric Surgery Based on Evidence from Subcutaneous Microdialysis and Populational Pharmacokinetic Modeling.

机构信息

Pharmacokinetics and PK/PD Modeling Laboratory, Pharmaceutical Sciences Graduate Program, Faculty of Pharmacy, Federal University of Rio Grande do Sul, Av. Ipiranga, 2752, Porto Alegre, RS, 90.610-000, Brazil.

Center for Obese Class III Care, Nossa Senhora Conceição Hospital (HNSC), Porto Alegre, RS, Brazil.

出版信息

Pharm Res. 2018 Apr 11;35(6):116. doi: 10.1007/s11095-018-2394-5.

DOI:10.1007/s11095-018-2394-5
PMID:29644481
Abstract

PURPOSE

To determine the efficacious cefazolin prophylactic dose for bariatric surgery using free subcutaneous concentrations accessed by microdialysis after 2 g or 3 g i.v. bolus dosing to morbidly obese women and POPPK modeling.

METHODS

A POPPK model with variable plasma and subcutaneous tissue protein binding was developed to simultaneously describe plasma and tissue data sets. The outcomes was predicted for common surgical site infection (SSI) bacteria over 3, 4, 5 and 6 h periods postdose, as probability of target attainment (PTA) using Monte Carlo simulation.

RESULTS

CFZ 2 g warrant up to 5 h SSI prophylaxis for bacteria with MICs ≤1 mg/L such as Escherichia coli and Staphylococcus aureus. For species such as Klebsiella pneumoniae, which present MIC distribution frequency of 2 mg/L, the maintenance of PTA ≥ 90% occurs with a 3 g dose for surgeries lasting up to 5 h, and 2 g dose provide an adequate response up to 4 h (PTA of 89%).

CONCLUSIONS

Effectiveness of CFZ 2 g is similar to 3 g against bacteria with a MIC up to 2 mg/L, especially if the surgery does not last for more than 4 h.

摘要

目的

通过对病态肥胖女性进行静脉推注 2g 或 3g 头孢唑林后,利用微透析法获取的游离皮下浓度,采用 POPPK 模型来确定用于肥胖症手术预防的头孢唑林有效剂量。

方法

建立了一个具有可变血浆和皮下组织蛋白结合的 POPPK 模型,以同时描述血浆和组织数据集。使用蒙特卡罗模拟,针对术后 3、4、5 和 6 小时的常见手术部位感染(SSI)细菌,将结局预测为目标达到率(PTA)。

结果

对于 MICs≤1mg/L 的细菌,如大肠杆菌和金黄色葡萄球菌,头孢唑林 2g 可保证长达 5 小时的 SSI 预防。对于 MIC 分布频率为 2mg/L 的细菌,如肺炎克雷伯菌,在手术持续时间不超过 5 小时的情况下,使用 3g 剂量可维持 PTA≥90%,而在 4 小时内,2g 剂量即可提供足够的反应(PTA 为 89%)。

结论

头孢唑林 2g 的有效性与 3g 相似,可预防 MIC 不超过 2mg/L 的细菌感染,尤其是手术持续时间不超过 4 小时的情况下。

相似文献

1
Efficacious Cefazolin Prophylactic Dose for Morbidly Obese Women Undergoing Bariatric Surgery Based on Evidence from Subcutaneous Microdialysis and Populational Pharmacokinetic Modeling.基于皮下微透析和群体药代动力学模型的证据,为病态肥胖女性接受减重手术时头孢唑林的有效预防剂量。
Pharm Res. 2018 Apr 11;35(6):116. doi: 10.1007/s11095-018-2394-5.
2
Optimal Cefazolin Prophylactic Dosing for Bariatric Surgery: No Need for Higher Doses or Intraoperative Redosing.减肥手术中头孢唑林的最佳预防性给药:无需更高剂量或术中再次给药。
Obes Surg. 2017 Mar;27(3):626-629. doi: 10.1007/s11695-016-2331-9.
3
Prophylactic cefazolin concentrations in morbidly obese patients undergoing sleeve gastrectomy: do we achieve targets?肥胖患者行胃袖状切除术时头孢唑林的预防浓度:我们能否达到目标?
Int J Antimicrob Agents. 2018 Jul;52(1):28-34. doi: 10.1016/j.ijantimicag.2018.02.015. Epub 2018 Mar 1.
4
Reduced subcutaneous tissue distribution of cefazolin in morbidly obese versus non-obese patients determined using clinical microdialysis.使用临床微透析法测定,与非肥胖患者相比,头孢唑林在病态肥胖患者皮下组织中的分布减少。
J Antimicrob Chemother. 2014 Mar;69(3):715-23. doi: 10.1093/jac/dkt444. Epub 2013 Nov 8.
5
Cefazolin tissue concentrations with a prophylactic dose administered before sleeve gastrectomy in obese patients: a single centre study in 116 patients.预防性给予头孢唑林剂量在肥胖患者行袖状胃切除术前的组织浓度:116 例患者的单中心研究。
Br J Anaesth. 2018 Jun;120(6):1202-1208. doi: 10.1016/j.bja.2017.10.023. Epub 2017 Dec 6.
6
Cefazolin dosing for surgical prophylaxis in morbidly obese patients.头孢唑林在病态肥胖患者手术预防中的给药剂量。
Surg Infect (Larchmt). 2012 Feb;13(1):33-7. doi: 10.1089/sur.2010.097. Epub 2012 Feb 8.
7
Pharmacokinetic and Pharmacodynamic Evaluation of a Weight-Based Dosing Regimen of Cefoxitin for Perioperative Surgical Prophylaxis in Obese and Morbidly Obese Patients.头孢西丁基于体重给药方案用于肥胖和病态肥胖患者围手术期手术预防的药代动力学和药效学评价
Antimicrob Agents Chemother. 2016 Sep 23;60(10):5885-93. doi: 10.1128/AAC.00585-16. Print 2016 Oct.
8
Prophylactic Cefazolin Dosing in Women With Body Mass Index >35 kg·m-2 Undergoing Cesarean Delivery: A Pharmacokinetic Study of Plasma and Interstitial Fluid.体质量指数>35kg·m-2 的剖宫产产妇中头孢唑林的预防用药剂量:血浆和间质液的药代动力学研究。
Anesth Analg. 2020 Jul;131(1):199-207. doi: 10.1213/ANE.0000000000004766.
9
Increased 3-gram cefazolin dosing for cesarean delivery prophylaxis in obese women.肥胖妇女剖宫产术预防应用头孢唑林 3 代剂量增加。
Am J Obstet Gynecol. 2015 Sep;213(3):415.e1-8. doi: 10.1016/j.ajog.2015.05.030. Epub 2015 May 21.
10
Pharmacokinetic characteristics and microbiologic appropriateness of cefazolin for perioperative antibiotic prophylaxis in elective cardiac surgery.头孢唑林用于择期心脏手术围手术期抗生素预防的药代动力学特征和微生物学适宜性。
J Thorac Cardiovasc Surg. 2016 Aug;152(2):603-10. doi: 10.1016/j.jtcvs.2016.04.024. Epub 2016 Apr 11.

引用本文的文献

1
Effective Antimicrobial Prophylaxis in Surgery: The Relevance and Role of Pharmacokinetics-Pharmacodynamics.手术中的有效抗菌预防:药代动力学-药效学的相关性及作用
Antibiotics (Basel). 2023 Dec 14;12(12):1738. doi: 10.3390/antibiotics12121738.
2
Prophylactic Cefazolin Dosing in Obesity-a Systematic Review.肥胖患者中头孢唑林的预防用药剂量:系统评价
Obes Surg. 2022 Sep;32(9):3138-3149. doi: 10.1007/s11695-022-06196-5. Epub 2022 Jul 9.
3
Plasma and Interstitial Fluid Pharmacokinetics of Prophylactic Cefazolin in Elective Bariatric Surgery Patients.

本文引用的文献

1
Fast and sensitive HPLC/UV method for cefazolin quantification in plasma and subcutaneous tissue microdialysate of humans and rodents applied to pharmacokinetic studies in obese individuals.用于人体和啮齿动物血浆及皮下组织微透析液中头孢唑林定量的快速灵敏的高效液相色谱/紫外法,应用于肥胖个体的药代动力学研究。
Biomed Chromatogr. 2018 Aug;32(8):e4254. doi: 10.1002/bmc.4254. Epub 2018 May 16.
2
Influence of Experimental Cryptococcal Meningitis in Wistar Rats on Voriconazole Brain Penetration Assessed by Microdialysis.通过微透析评估实验性隐球菌性脑膜炎对Wistar大鼠伏立康唑脑穿透性的影响。
Antimicrob Agents Chemother. 2017 Jun 27;61(7). doi: 10.1128/AAC.00321-17. Print 2017 Jul.
3
择期减肥手术患者中头孢唑林预防用药的血浆和间质液药代动力学。
Antimicrob Agents Chemother. 2022 Jul 19;66(7):e0041922. doi: 10.1128/aac.00419-22. Epub 2022 Jun 28.
4
A validated LC-MS/MS method for the quantitation of cefazolin in human adipose tissue: Application of EMR-Lipid sorbent as an efficient sample clean-up before mass spectrometric analyses.一种用于定量人脂肪组织中头孢唑林的 LC-MS/MS 验证方法:在质谱分析前,EMR-Lipid 吸附剂作为一种有效的样品净化方法的应用。
J Pharm Biomed Anal. 2022 May 10;213:114696. doi: 10.1016/j.jpba.2022.114696. Epub 2022 Feb 28.
Population Pharmacokinetics of Cefazolin in Serum and Adipose Tissue From Overweight and Obese Women Undergoing Cesarean Delivery.
剖宫产超重及肥胖女性血清和脂肪组织中头孢唑林的群体药代动力学
J Clin Pharmacol. 2017 Jun;57(6):712-719. doi: 10.1002/jcph.851. Epub 2016 Dec 7.
4
Association between Pre-Operative Cefazolin Dose and Surgical Site Infection in Obese Patients.肥胖患者术前头孢唑林剂量与手术部位感染之间的关联
Surg Infect (Larchmt). 2017 May/Jun;18(4):485-490. doi: 10.1089/sur.2016.182. Epub 2016 Dec 1.
5
New WHO recommendations on intraoperative and postoperative measures for surgical site infection prevention: an evidence-based global perspective.世界卫生组织关于手术部位感染预防的术中及术后措施新建议:基于证据的全球视角。
Lancet Infect Dis. 2016 Dec;16(12):e288-e303. doi: 10.1016/S1473-3099(16)30402-9. Epub 2016 Nov 2.
6
New WHO recommendations on preoperative measures for surgical site infection prevention: an evidence-based global perspective.世界卫生组织关于手术部位感染预防的术前措施新建议:基于证据的全球视角。
Lancet Infect Dis. 2016 Dec;16(12):e276-e287. doi: 10.1016/S1473-3099(16)30398-X. Epub 2016 Nov 2.
7
Optimal Cefazolin Prophylactic Dosing for Bariatric Surgery: No Need for Higher Doses or Intraoperative Redosing.减肥手术中头孢唑林的最佳预防性给药:无需更高剂量或术中再次给药。
Obes Surg. 2017 Mar;27(3):626-629. doi: 10.1007/s11695-016-2331-9.
8
Trends in Obesity Among Adults in the United States, 2005 to 2014.2005年至2014年美国成年人肥胖趋势
JAMA. 2016 Jun 7;315(21):2284-91. doi: 10.1001/jama.2016.6458.
9
Obesity and the Risk for Surgical Site Infection in Abdominal Surgery.肥胖与腹部手术手术部位感染风险
Am Surg. 2016 Apr;82(4):331-6.
10
Bariatric surgery implementation trends in the USA from 2002 to 2012.2002年至2012年美国减肥手术的实施趋势。
Implement Sci. 2016 Feb 20;11:21. doi: 10.1186/s13012-016-0382-x.